TO CLOSE

The parents of 27-year-old William Plott describe their treatment history of their epileptic son's drugs.
Albert Cesare, [email protected]

Buy a photo

William Plott, 27, who has suffered severe epileptic seizures since the age of six months, caresses his father, Glenn Plott, to the head on Sunday, June 17, 2018, at their Cincinnati home. William Plott is currently being treated for his epilepsy with a combination of drugs, one being a derivative of marijuana. William never developed the ability to speak.(Photo: Albert Cesare / The Enquirer)Buy a photo

Over the past three years, a large black safe from the Medical Arts Building at the University of Cincinnati has stocked medical marijuana reserves of Dr. Michael Privitera.

A lifetime researcher on the mystery of brain seizures, Privitera was conducting a clinical study on a medical-marijuana drug and epilepsy. Under scrutiny by the government, the study yielded astonishing results as Monday, the US Food and Drug Administration approved the drug, Epidiolex, the first time the government signed a treatment of the disease made from the marijuana plant.

"It's historic," said Privitera. "We did the right kind of science, we took the anecdotal evidence, extracted the substance in marijuana, tested it, and followed the test guidelines for all the other drugs." really, and we can make sure it's safe. "

One participant in the study is William Plott, 27, from Westwood, who has suffered seizures almost his entire life. Glenn and Cbadandra Plott have said that Epidiolex has so facilitated the raging electric storm in their son's brain that he can now do simple things for the first time, such as making eye contact. "We feel lucky to be part of the study," said Cbad Plott.

Buy a photo

William Plott, 27, who has suffered severe epileptic seizures since the age of six months, kisses his mother, Cbadandra Plott, while his father, Glenn Plott, watches the newspaper on Sunday, June 17, 2018 at home in Cincinnati. Plott is currently being treated for his epilepsy with a combination of drugs, one being a derivative of marijuana. (Photo: Albert Cesare / The Enquirer)

The action of the FDA could be significant for marijuana itself. Since 1970, the federal government has listed marijuana on its Annex I the most dangerous substances with no therapeutic value. With marijuana performing impressively under tight controls, the pressure is likely to push the drug off the federal list all bad, which would broaden the horizons for research and development.

How a little girl led the way

Among the most fervent supporters of medical marijuana in the country are families of children with epilepsy. In 2013, their network was illuminated with news of a Colorado girl, Charlotte Figi, who had suffered hundreds of seizures a day. No medicine controlled his illness, so his desperate parents turned to marijuana.

Humans have used marijuana as a medicine for thousands of years. It's only recently that science has learned that marijuana – the Latin name for cannabis – contains dozens of intriguing compounds. One, cannabidiol or CBD, has shown an early promise in controlling seizures without the effect altering the spirit of marijuana, caused by its best-known compound, the delta-9- tetrahydrocannabinol or THC.

The Figis worked with Colorado developers to create a CBD-rich oil, and he worked on Charlotte. The word "Charlotte's Web" circulated on the Internet, and a wave of families moved to Colorado to get a doctor's recommendation to treat their sick children with CBD patches, oils, and lotions. The Plotts debated the move, too.

"The most complicated study"

Privitera founded and directs the Epilepsy Center of the UC Gardner Neuroscience Institute. He read about Charlotte Web Oil and decided that he was ready to study anything to fight the debilitating disease that affects one million Americans.

Buy a photo

Dr. Michael Privitera is holding his replica of the human brain at the UC Department of Hospital Neurology on Thursday, June 14, 2018 in Cincinnati. (Photo: Albert Cesare / The Enquirer)

The friend of Privitera, Dr. Orrin Devinsky, of The Langone Full Epilepsy Center at New York University, was launching a rigorous study on a pure-CBD oil manufactured by the British company GW Pharmaceuticals.

A group of subjects would receive a low dose of Epidiolex. One group received a high dose. A third received a placebo. Neither the doctors nor the patients will know who gets what. The hope was to curb the Lennox-Gastaut syndrome, which triggers terrifying "flare-ups" that crush the stop button in the brain. The body becomes blocked and gravity takes over, often resulting in crippling head injuries.

GW Pharmaceuticals was paying for the study. Privitera was determined to include UC. Devinsky warned: not only would the FDA oversee, but the US Drug Enforcement Administration.

Privitera said no problem, but, "I did not realize what I was signing for .I have been doing this job for 30 years, and it was by far the most complicated study and the most more difficult than we had to do. "

The DEA, an anti-crime and prohibition agency, is rarely involved in medical research. "The first time the DEA person came, he sat down and said," Tell me what is epilepsy, "said Privitera. The doctor explained that epilepsy is a generic term for seizure disorders caused by short circuits in brain wiring

The easy part: recruiting patients

The DEA required exceptionally intensified controls for the drug, including the large black safe in the Medical Arts Building for storage. To participate in the study, Privitera first needed an Appendix I license, which required a nine-month review including fingerprints.

The drug could only be dispensed from the address listed on the license of Schedule I of Privitera, the Medical Arts Building.

The DEA would review the records only at each audit, coordinating nurse Donna Schwieterman rolled a full cart from Privitera's office in the Stetson Building to the Medical Arts Building across the busy Martin Luther Boulevard. King.

Privitera had to account for every drop of Epidiolex. Every bottle that left the building had to be returned, empty or not. Privitera had to hire an elimination company to collect and destroy the bottles and the remains of oil.

The study began as the marijuana landscape in Ohio changed. A well-funded 2015 campaign for full legalization failed 2-1, but polls showed that Ohio residents wanted to have access to marijuana as a medicine. The Ohio General Assembly created a medical program in June 2016. Although not a fan, Republican Governor John Kasich signed the bill.

The easiest part of the Epidiolex study was by far the recruitment of subjects. "The patients involved, I must say, were really brave," said Privitera. "Even people who have not had any benefit have all said," I would do it again, to help other people with epilepsy. "

The story of William

The Plotts read about Charlotte's oil and took hope.

Glenn Plott, 61, has been director of production at the Cincinnati Opera House for about 20 years. Cbad Plott, 62, is a professional quilt who takes care of William full time. They have a younger son, Jeremy.

Buy a photo

A piece of plywood is placed over the oven where William Plott, 27, who has suffered severe epileptic seizures since the age of six months, has fallen several times after having a seizure. # 39; epilepsy. in Cincinnati. William Plott is currently being treated for his epilepsy with a combination of drugs, one being a derivative of marijuana. William never developed the ability to speak. (Photo: Albert Cesare / The Enquirer)

The Plotts say that foreclosures began in 1991 when William was 6 months old, and he "fell off the map of development," said Cbad Plott, beginning of the pharmaceutical odyssey. for a long time. William's seizures were long, frequent, and severe, forcing to wear a helmet No genetic, organic or structural cause was found.

With a combination of heavy drug, William got a Wave Nerve Stimulator, an implant that sends electrical signals to the brain. He does not speak. He can not take care of himself. Plots keep scrupulous notes on William in large three-ring binders.

William's neurologist, David Ficker, is a colleague of Privitera at the Neuroscience Institute. When the Plotts envisioned a move to Colorado, Ficker suggested involving William in the Epidiolex study. First documents and reviews to establish baselines, but one day, late 2015, Cbad filled an oral syringe with Epidiolex. It smelled like strawberries. She spurted it into William's mouth. He swallowed it.

Dealing with the "catch of gout"

The 14-week study was launched at sites in England, Spain and the United States, including UC and the Nationwide Children's Hospital in Columbus. The 225 patients ranged from 2 and 55 and had two or more fall seizures per week.

The large black safe on the third floor of the Medical Arts Building quickly filled the white boxes of GW Pharmaceuticals. The DEA only allowed Privitera, Ficker and other UC physicians to open the combined safe, which was located behind a double-lock door with the keys in a locked box in a other room. The DEA has also conducted surprise inspections of the study site.

The resounding results were published in March in the prestigious New England Journal of Medicine. The average reduction in gout attacks was 37 percent at a dose of 10 mg and 41 percent at a dose of 20 mg. Even placebo patients had a 17% reduction. In some patients, said Privitera, the decline was as high as 90 percent.

Drug could be in stores by end of the year

The medicine is safe. The most serious side effects were drowsiness, loss of appetite and diarrhea – which is not surprising, said Privitera, since patients consumed a lot of oil through the # 39; study. In April, an FDA review panel voted 13-0 in April to recommend approval. The final OK June 25 means that the drug could be in pharmacies by the end of the year.

For all the work to test the drug, the study revealed nothing except that CBD oil reduces seizures. "We do not know how it works, we do not know why it works, but it works," said Privitera. "Now it's time to do more research."

The restrictions imposed by the government on the study of an Schedule I drug make the research extremely expensive. The FDA's approval for Epidiolex could show that researchers can handle medical marijuana studies as they do for any other experimental drug, without the involvement of the police, or the need for a large chest -fort.

Ohio is the 25th state to adopt a medical marijuana program, which officially begins Sept. 8, although drug production is late by several months. Doctors certified by the Ohio Medical Board can write recommendations for 21 qualifying conditions, including epilepsy.

Buy a photo

William Plott, 27, who has suffered severe epileptic seizures since the age of one, sleeps in bed on Sunday, June 17, 2018, at his parents' home in Cincinnati. Plott is currently being treated for his epilepsy with a combination of drugs, one being a derivative of marijuana. (Photo: Albert Cesare / The Enquirer)

Which CBD oil revealed in William

"We are not in the state of mind of madness reefer," said Cbad Plott. "We are not people who seem to be high". But during a conversation about Father's Day at their Westwood home, the Plotts say that they believe in the CBD. They only need to look at their William notebooks to follow significant improvement over more than two years.

The change was so dramatic that "we knew almost immediately that he was not on the placebo," Cbad said. For a moment, William's appetite exploded. Glenn said he and Cbad were wondering, "Does he have cravings?"

William used to have 1000 seizures a year. Now, there are about 200 who are less severe, although a fall in early June broke his collarbone. It takes 15.2 milligrams of Epidiolex a day. He goes to a day program at the Center of practical life at Mount Healthy.

The biggest improvement, said the Plotts, is that William can express himself. Slowly, little by little, their adult son reveals himself.

"He knows how to stay away from my mail, but sometimes we'll watch him walk, you see me, do you see me? It's one of his favorite things" said Glenn. "It's funny, like having a child 5 feet 6 in the house."

On Father's Day, William orbited the rooms of his house, then headed for the kitchen. His mother drove William to his room, where he fell into bed and beamed when she lined it. The nap was brief, however, and William rose again. He grabbed his mother's hand and headed for the front door. He wanted to go outside.

Read or share this story: https://cin.ci/2MtgQE8